Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NOC2L Inhibitors

Chemical inhibitors of Nucleolar complex protein 2 homolog (NOC2L) encompass a diverse array of compounds, each potentially impacting the protein through different cellular mechanisms. Plitidepsin, acting as an eEF1A2 inhibitor, may impede protein synthesis processes, potentially influencing NOC2L's role in the nucleolus, given its involvement in ribosomal biogenesis. Actinomycin D, by binding DNA and inhibiting RNA polymerase, could affect gene expression regulation, an area where NOC2L is speculated to have a role. Similarly, CX-5461 and BMH-21, both targeting RNA polymerase I, might directly impact the ribosomal RNA synthesis process, thereby influencing NOC2L's nucleolar functions. Rapamycin, an mTOR inhibitor, may alter NOC2L's function indirectly by affecting pathways involved in cell growth and proliferation, which are crucial for nucleolar activities. Leptomycin B, by inhibiting nuclear export, could influence NOC2L's cellular localization and consequently its functional efficiency in the nucleolus. Triptolide, known for its transcription-inhibiting properties, might impact NOC2L's role in gene regulation, a key aspect of nucleolar function. EX 527, as a SIRT1 inhibitor, could alter deacetylation processes, potentially affecting NOC2L's regulation or interaction with other proteins. Bortezomib's role in inhibiting proteasome activity might affect protein degradation pathways relevant to NOC2L, while Olaparib, as a PARP inhibitor, might impact NOC2L's involvement in DNA repair processes. Suberoylanilide Hydroxamic Acid, an HDAC inhibitor, could influence NOC2L by altering histone acetylation and subsequent gene expression, thereby affecting its nucleolar activities. Lastly, Thalidomide, affecting the ubiquitin-proteasome system, might indirectly influence NOC2L's stability or protein-protein interactions, crucial for its functional integrity. Each of these inhibitors, though not directly targeting NOC2L, could modulate the protein's function or expression by influencing various pathways and cellular processes with which NOC2L is associated.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA polymerase, possibly affecting NOC2L's role in gene expression.

CX-5461

1138549-36-6sc-507275
5 mg
$245.00
(0)

CX-5461 inhibits RNA polymerase I, potentially impacting NOC2L's nucleolar functions.

BMH-21

896705-16-1sc-507460
10 mg
$165.00
(0)

BMH-21 inhibits RNA polymerase I and could affect NOC2L's involvement in ribosomal RNA synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which might indirectly affect NOC2L's function in cell growth and proliferation.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Leptomycin B inhibits nuclear export, which could influence NOC2L's cellular localization and function.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide inhibits transcription and might impact NOC2L's role in gene regulation.

EX 527

49843-98-3sc-203044
5 mg
$87.00
32
(1)

EX 527, a SIRT1 inhibitor, could affect NOC2L by modulating deacetylation processes.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits proteasome activity, potentially affecting protein degradation pathways relevant to NOC2L.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

Olaparib, a PARP inhibitor, might influence NOC2L's function in DNA repair processes.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid, an HDAC inhibitor, could affect NOC2L by altering histone acetylation and gene expression.